7°啡得乐饮料

Search documents
多措并举释放增长动能 陇神戎发上半年净利润同比增长27.48%
Zheng Quan Ri Bao Zhi Sheng· 2025-08-22 14:09
Core Viewpoint - Gansu Longshen Rongfa Pharmaceutical Co., Ltd. reported a steady growth in revenue and net profit for the first half of 2025, demonstrating resilience amid a challenging economic environment [1][2]. Financial Performance - The company achieved an operating income of 496 million yuan and a net profit attributable to shareholders of 27.96 million yuan, representing a year-on-year increase of 27.48% [1]. - The net profit excluding non-recurring gains and losses was 30.49 million yuan, up 39.93% year-on-year [1]. Market Strategy - The company focused on enhancing its marketing efforts, particularly in promoting its major products, with the coverage of its flagship products reaching 2,858 hospitals for Yuanhu Zhiting Diban and 2,299 hospitals for Xuanfei Zhiso Heji, marking coverage increases to 19.39% and 15.56% respectively [2]. - Revenue from the droplet products grew by 31.22% year-on-year, contributing to overall performance improvement [2]. Project Development - The company completed the acquisition of 70% of the Gansu Pharmaceutical Group Technology Innovation Research Institute, enhancing its drug research and development capabilities [3]. - Upgrades to the production line for Xuanfei Zhiso Heji were completed, achieving compliance with GMP standards, which will boost production capacity [3]. - The construction of a production line for a new type of medical device is progressing, which is expected to create new business growth opportunities [3]. Research and Development - A technical center laboratory was established in collaboration with a subsidiary, improving the R&D infrastructure and facilitating the transition from laboratory to industrial production [4]. - Ongoing development of main products includes real-world studies for Xuanfei Zhiso Heji and Yuanhu Zhiting Diban, as well as collaborations with Lanzhou University for health food R&D [4]. Investor Returns and Social Responsibility - The company plans to distribute cash dividends of 0.2 yuan per 10 shares, totaling 6.07 million yuan [4]. - The company has been recognized for its commitment to green development and has made donations of 1 million yuan to support areas affected by recent natural disasters [4].